PUBLICATIONS IN SCIENTIFIC JOURNALS
45. «Multiscale time-resolved fluorescence study of a glycogen phosphorylase inhibitor combined with quantum chemistry calculations» V. Maffeis, K. Mavreas, F. Monti, M. Mamais, T. Gustavsson, E. D. Chrysina, D. Markovitsi,* T. Gimisis* & A. Venturini* 2019, in press. https://doi.org/10.1039/C8CP07538G
42. «A New Potent Inhibitor of Glycogen Phosphorylase Reveals the Basicity of the Catalytic Site» M. Mamais, A. Degli Esposti, V. Kouloumoundra,
T. Gustavsson, F. Monti, A. Venturini,* E. D. Chrysina,* D. Markovitsi,* T. Gimisis* Chem. Eur. J. 2017, 23, 8800 – 8805. https://doi.org/10.1002/chem.201701591
Featured in Frontispiece Cover: https://doi.org/10.1002/chem.201783763
In this paper, a previously unknown property of the catalytic site of glycogen phosphorylase (GP) and specifically the catalytic site’s basicity has been revealed by using a photochemical fluorescent probe and at the same time one of the most potent catalytic site GP inhibitors that have been reported to date. The article was showcased by the journal with a frontispiece graphic.
2. «Synthesis of N4-aryl-β-D-glucopyranosylcytosines: a methodology study» Mamais, Μ.; Kouloumoundra, V.; Smyrli, E.; Grammatopoulos, P.; Chrysina, E.D.; Gimisis, T.* Tetrahedron Lett. 2015, 56, 5549–5552.
A synthetic methodology paper describing optimized conditions for obtaining the title compounds which are lead compounds for the proposed work.
3. “Synthesis of N-glucopyranosidic derivatives as potential inhibitors that bind at the catalytic site of glycogen phosphorylase”Gimisis, T. Mini Rev. Med. Chem. 2010, 10(12) 1127-1138.
Invited Review with 60 refs. 21 Citations
4. “Naturally Occurring Pentacyclic Triterpenes as Inhibitors of Glycogen Phosphorylase: Synthesis, Structure-Activity Relationships and X-ray Crystallographic Studies” Wen, X.; Sun, H.; Liu, J.; Cheng, K.; Zhang, P.; Zhang, L.; Hao, J.; Zhang, L.; Ni, P.; Zographos, S.E.; Leonidas, D.D.; Alexacou, K-M.; Gimisis, T.; Hayes, J.M.; Oikonomakos, J. Med. Chem. 2008, 51, 3540-3554. >180 citations
5. “FR258900, a Potential Anti-hyperglycemic Drug, Binds at the Allosteric Site of Glycogen Phosphorylase” C. Tiraidis, KM Alexacou, SE Zographos, DL Leonidas, T. Gimisis, NG Oikonomakos, Protein Sci. 2007, 16, 1773-1782. >17 Citations
6. “Binding of Oxalyl Derivatives of β-D-glucopyranosylamine to Muscle Glycogen Phosphorylase b” Hadjiloi, T.; Tiraidis, C.; Chrysina, E. D.; Leonidas, D. D.; Oikonomakos, N. G.; Tsipos, P.; Gimisis, T. Bioorg. Med. Chem. 2006, 14, 3872-3882. Featured on the Journal Cover Page >12 Citations
PUBLICATIONS IN CONFERENCE PROCEEDINGS AND PRESENTATIONS
22. «Synthesis of β-C-glucopyranosyl analogues of natural nucleosides »
K. Mavreas, T. Gimisis* National Chemistry Symposium, AUTH, December 2016
21. «Glycogen Phosphorylase Inhibitors: Synthesis, Kinetics, Crystallography and in vivo Studies of New Hypoglycemic Agents» Thanasis Gimisis Oral Presentation in Program of Excellence “New drug transport systems in nanomedicine» NKUA, 13/7/2015.
20. «4-arylamino-β-D-glucopyranosyl-pyrimidines: exploring the catalytic site of glycogen phosphorylase for the design of new antidiabetic agents” Poster presentation Michail D. Mamais, Thanasis I. Gimisis, Evangelia D. Chrysina, 11th Biology and Synchrotron Radiation International Conference (11thBSR), Hamburg, 8-11/9/2013.
19. “4-arylamino-β-D-glucopyranosyl-pyrimidines: exploring the catalytic site of glycogen phosphorylase” Michail D. Mamais, Thanasis I. Gimisis, Evangelia D. Chrysina, 15th Hellenic Medicinal Chemistry Symposium, NRF, 25-27/5/2012.
18. «4-arylamino-β-D-glucopyranosyl-pyrimidines: 4-αρυλαμινο-β-D-γλυκοπυρανοζυλο-πυριμιδίνες: exploring the catalytic site of glycogen phosphorylase » M.D. Mamais, T. Gimisis, E.D. Chrysina, 21st National Chemistry Symposium, AUTH, 9-12/12/2011.
17. “Exploring the Catalytic Site of Glycogen Phosphorylase with β-D-Glucopyranosyl-Nucleoside Inhibitors” T. Gimisis, (Invited Lecture), Structural Biology & Chemistry Symposium, Athens, Greece, 30 – 31 October, 2009.
16. “Molecular modelling of β-D-glucose pyrimidine derivatives binding at the catalytic site of glycogen phosphorylase” Poster Presentation M. Mamais, J.M. Hayes, T. Gimisis, E.D. Chrysina, 3rd National Organic Chemistry Symposium, NKUA, 15-17/10/2009.
15. “Looking for potent inhibitors of glycogen phosphorylase: the structure-based ligand design approach in vitro & in silico” Lecture (L07) E.D. Chrysina, J.M. Hayes, M. Mamais, E. Lazoura, T. Gimisis, 3rd National Organic Chemistry Symposium, NKUA, 15-17/10/2009.
14. “The biochemist’s routine is the organic chemist’s dream: Obtaining small molecule crystal data without crystallization. The case of glycogen phosphorylase inhibitors based on β-D-glucopyranosyl-nucleosides” T. Gimisis, P. Grammatopoulos, M. Mamais, D. Sovantzis, K.-M. Alexacou, S. E. Zographos, D. D. Leonidas, E. Chrysina, J. M. Hayes, N. G. Oikonomakos,† 4th Conference, Hellenic Crystallographic Association, Athens, 26 – 27/9/2008.
13. «1+1=3: Synthesis of potential inhibitors of glycogen phosphorylase, solves problems in oxidative DNA damage and offers crystal structures without crystallization» T. Gimisis, Invited Lecture, Summer School «Organic Synthesis and Applications in Chemical Industry», Andros, 27–30/8/2008
12. “Pentacyclic triterpenes, inhibitors of glycogen phosphorylase, as potential drugs for type 2 diabetes: X-ray crystallographic studies” S. E. Zographos, D. D. Leonidas, K. M. Alexacou, T. Gimisis, J. M. Hayes, N. G. Oikonomakos, X. Wen, H. Sun, J. Liu, K. Cheng, P. Zhang, L. Zhang, J. Hao, L. Zhang, P. Ni 7th Joint Meeting of GA, AFERP, ASP, PSE & SIF, Athens, Greece,3–8/8/2008 Published in: Planta Medica, 2008, 74, 1146-1147. (I.F.: 2,089)
11. “Synthesis and Protein Crystallography of Urea-Tethered Gluco-amino acids as Potential Inhibitors of Glycogen Phosphorylase” Poster Presentation A. Stathi, D. Sovatzis, S. Zographos, D. Leonidas, N. Oikonomakos, T. Gimisis 13th National Pharmaceutical Chemistry Symposium, Athens, 13-15/3/2008.
10. “Structure determination of DNA base lesions through oxidation of gluconucleosides and synthesis, coupled with protein crystallography” D. Stathis, T. Gimisis Lecture, 7th Semi-Annual Meeting of RTN program on “Selective Formation & Biochemistry of Oxidative Clustered DNA Damage” Plovdiv, Bulgaria, 2–6/6/2007.
9. «Deciphering the structure of oxidative DNA damage products through independent synthesis and protein crystallography » Αθ. Γκιμήσης, Invited Lecture, 2nd National Organic Synthesis Symposium, NKUA 19-21/4/2007
Supervised Doctoral Theses within the subject of the proposal
1. Michail Mamais: “Synthesis, Kinetics and Crystallographic Study of potential inhibitors of glycogen phosphorylase” (Financed from Heraklitos II Program) 2010-2015
2. Virginia Kouloumoundra: “In vitro and in vivo study of synthetic inhibitors of glycogen phosphorylase as potential antidiabetic drugs” 2014-2016
3. Konstantinos Fioravantes Mavreas: “Synthesis and Study of C-glucopyranosides with possible pharmacological activity” 2016-present IKY Fellowship recipient through the program: “Strengthening human research potential through doctoral research”
Supervised Master’s Theses within the subject of the proposal
11. Dimitrios Kontomarkos: “Synthesis of the aglycon and derivatives of known inhibitors of glycogen phosphorylase: Study of the effect of the inhibition constant” 2016
10. Konstantinos Fioravantes Mavreas: “Synthesis of C-glucopyranosyl analogues of natural nucleotides with potential pharmacological activity” 2016
9. Virginia Kouloumoundra: “Synthesis of novel strong inhibitors of glycogen phosphorylase using aryl-benzylamines” 2014
8. Evgenia Smyrli: “Synthesis of N4- and N3-aryl derivatives of β-D-glucopyranosyl pyrimidines as inhibitors of glycogen phosphorylase” 2014
7. Michail Mamais: “In silico and in vitro studies of β-D-glucopyranosyl pyrimidines as potential antidiabetic drugs” 2009
6. Dimitrios Sovantzis: “Inhibitors of glycogen phosphorylase as potential antidiabetic drugs” (Organic Chemistry Laboratory) 2009
5. Aggeliki Stathi: “Synthesis of β-D-glucopyranosyl spiro nucleosides and β-D-glucopyranosyl-aminocarbonyl amino acids as potential inhibitors of glycogen phosphorylase” 2008
4. Paschalis Grammatopoulos: “Synthesis of second generation inhibitors of glycogen phosphorylase based on β-D-glycopyranosyl uridine” 2008
Supervised Undergraduate Theses within the subject of the proposal
15. Petros Baltimas, Adamantia Koroba: “Synthesis and spectral study of N1-(β-D-glucopyranosyl)-N2-(5-benzimidazolyl)-cytosines as potential inhibitors of glycogen phosphorylase” 2017
14. Irini Emmanouil, Michalis Minadakis: “Synthesis of β-D-glucopyranosyl pyrimidine derivatives as potential inhibitors of glycogen phosphorylase and photometric determination of the pKa of catalytic site inhibitors” 2017
13. Nikos Giannopoulos, Emmanouil Broumidis: “Development of a synthetic methodology for the synthesis of N1-(β-D-glucopyranosyl)-N4-(2-aryl-1,3-dioxoisoindolin-5-yl)-cytosines” 2016
12. Giorgos Mazis, Giorgos Misiakos: “Synthesis of N1-(β-D-glucopyranosyl)-N4-(3-acylphenyl) cytosines as potential inhibitors of glycogen phosphorylase” 2015
11. Aggelos Kitsikis, Basia Papanikolaou: “Development of a methodology for the synthesis of β-D-pyranosyl-diurea” 2015
10. Emilia Rigakou, Konstantina Iliou: “Synthesis of benzylamines from substituted benzaldehydes and their use in the synthesis of new inhibitors of glycogen phosphorylase” 2015
9. Theodora Koutsikou, Anna Lada: “Synthesis of β-D-glucopyranosyl pyrimidines as potential inhibitors of glycogen phosphorylase” 2014
8. Ioli Aggeliki Kotsogianni-Teftsoglou, Konstantinos Fioravantes Mavreas: “Study of the substitution reaction of 4-position triazole pyrimidines by unreactive heterocyclic arylamines” 2014
7. Eftychia Kavvadia: “Synthesis of 4-arylamino-β-D-glucopyranosyl pyrimidines, with the method of substitution of 1,2,4-triazoles, as inhibitors of glycogen phosphorylase” 2014
6. Stella Konstantopoulou: “Study of the 4-position substitution of β-D-glucopyranosyl uracil via 1,2,4 triazolyl derivatives” 2013
5. Maria Papageorgiou, Nadia Othman: “Synthesis of 4-aryloxy and 4-arylamine derivatives of N4-phenyl-N1-(β-D-glucopyranosyl) cytosine as strong inhibitors of glycogen phosphorylase” 2012